"Parasympatholytics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
| Descriptor ID |
D010276
|
| MeSH Number(s) |
D27.505.696.663.050.650
|
| Concept/Terms |
Parasympatholytics- Parasympatholytics
- Parasympatholytic Drugs
- Drugs, Parasympatholytic
- Parasympathetic-Blocking Agents
- Agents, Parasympathetic-Blocking
- Parasympathetic Blocking Agents
- Parasympatholytic Agents
- Agents, Parasympatholytic
Parasympatholytic Effect- Parasympatholytic Effect
- Effect, Parasympatholytic
- Parasympatholytic Effects
- Effects, Parasympatholytic
Antispasmodic Effect- Antispasmodic Effect
- Effect, Antispasmodic
- Antispasmodic Effects
- Effects, Antispasmodic
Antispasmodics- Antispasmodics
- Antispasmodic Drugs
- Drugs, Antispasmodic
- Spasmolytics
- Antispasmodic Agents
- Agents, Antispasmodic
|
Below are MeSH descriptors whose meaning is more general than "Parasympatholytics".
Below are MeSH descriptors whose meaning is more specific than "Parasympatholytics".
This graph shows the total number of publications written about "Parasympatholytics" by people in this website by year, and whether "Parasympatholytics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2007 | 1 | 1 | 2 |
| 2009 | 2 | 0 | 2 |
| 2012 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parasympatholytics" by people in Profiles.
-
Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol. 2018 04; 218(4):390-400.
-
Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system. Circ Arrhythm Electrophysiol. 2012 Aug 01; 5(4):850-9.
-
Fear no pain: uterine cavity and tubal patency assessment tests should be pain free. Ultrasound Obstet Gynecol. 2012 Mar; 39(3):247-51.
-
Constipation. Dis Mon. 2011 Sep; 57(9):511-7.
-
Extended-release trospium chloride improves quality of life in overactive bladder. Value Health. 2010 Mar-Apr; 13(2):251-7.
-
Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec; 20(12):1431-8.
-
Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial. J Urol. 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4.
-
Virtual colonoscopy: technique and accuracy. Radiol Clin North Am. 2007 Mar; 45(2):333-45.
-
Spectral analysis of left ventricular area variability as a tool to improve the understanding of cardiac autonomic control. Physiol Meas. 2000 May; 21(2):319-31.
-
Selective restoration of calcium coupling to muscarinic M(3) receptors in contractile cultured airway myocytes. Am J Physiol Lung Cell Mol Physiol. 2000 May; 278(5):L1091-100.